Impact of Obesity on Clinicopathologic Characteristics and Disease Prognosis in Pre- and Postmenopausal Breast Cancer Patients: A Retrospective Institutional Study

Figure 1

Association of BMI with receptor status and molecular subtype in breast cancer patients at time of diagnosis. BMI among all patients, premenopausal cases, and postmenopausal cases in relation to (a) ER, (b) PR, (c) HER2, and (d) molecular subtype. Bars represent mean BMI value ± SEM. BMI, body mass index; ER, estrogen receptor; HER2, human epidermal growth factor receptor 2; PR, progesterone receptor.

(a)

(b)

(c)

(d)